Dermaprazole Cream for Radiation Dermatitis in Definitive Head and Neck Cancer
Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
In this study, the study team seek to conduct a pilot clinical study to evaluate the safety
and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive
head and neck cancer (HNC) patients.